Literature DB >> 35372924

Does Vascular Access Type Affect Access-Related Costs?

Mae Thamer1.   

Abstract

Entities:  

Keywords:  Anti-Inflammatory Agents; Diabetes and the Kidney; Diabetic Nephropathies; Inflammation; Pentoxifylline; Sodium-Glucose Transporter 2 Inhibitors; Standard of Care

Mesh：

Year:  2020        PMID： 35372924      PMCID： PMC8809280          DOI： 10.34067/KID.0000752020

Source DB:  PubMed          Journal:  Kidney360        ISSN： 2641-7650


× No keyword cloud information.
  9 in total

1.  Vascular access choice in incident hemodialysis patients: a decision analysis.

Authors:  David A Drew; Charmaine E Lok; Joshua T Cohen; Martin Wagner; Navdeep Tangri; Daniel E Weiner
Journal:  J Am Soc Nephrol       Date:  2014-07-25       Impact factor: 10.121

Review 2.  Associations between hemodialysis access type and clinical outcomes: a systematic review.

Authors:  Pietro Ravani; Suetonia C Palmer; Matthew J Oliver; Robert R Quinn; Jennifer M MacRae; Davina J Tai; Neesh I Pannu; Chandra Thomas; Brenda R Hemmelgarn; Jonathan C Craig; Braden Manns; Marcello Tonelli; Giovanni F M Strippoli; Matthew T James
Journal:  J Am Soc Nephrol       Date:  2013-02-21       Impact factor: 10.121

3.  Tradeoffs in Vascular Access Selection in Elderly Patients Initiating Hemodialysis With a Catheter.

Authors:  Timmy Lee; Joyce Qian; Mae Thamer; Michael Allon
Journal:  Am J Kidney Dis       Date:  2018-05-18       Impact factor: 8.860

4.  Type of vascular access and mortality in U.S. hemodialysis patients.

Authors:  R K Dhingra; E W Young; T E Hulbert-Shearon; S F Leavey; F K Port
Journal:  Kidney Int       Date:  2001-10       Impact factor: 10.612

5.  Establishment and maintenance of vascular access in incident hemodialysis patients: a prospective cost analysis.

Authors:  Braden Manns; Marcello Tonelli; Serdar Yilmaz; Helen Lee; Kevin Laupland; Scott Klarenbach; Val Radkevich; Brendan Murphy
Journal:  J Am Soc Nephrol       Date:  2004-11-24       Impact factor: 10.121

6.  Cost-effectiveness of vascular access for haemodialysis: arteriovenous fistulas versus arteriovenous grafts.

Authors:  J J P M Leermakers; A S Bode; A Vaidya; F M van der Sande; S M A A Evers; J H M Tordoir
Journal:  Eur J Vasc Endovasc Surg       Date:  2012-11-13       Impact factor: 7.069

7.  Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial.

Authors:  Laura M Dember; Gerald J Beck; Michael Allon; James A Delmez; Bradley S Dixon; Arthur Greenberg; Jonathan Himmelfarb; Miguel A Vazquez; Jennifer J Gassman; Tom Greene; Milena K Radeva; Gregory L Braden; T Alp Ikizler; Michael V Rocco; Ingemar J Davidson; James S Kaufman; Catherine M Meyers; John W Kusek; Harold I Feldman
Journal:  JAMA       Date:  2008-05-14       Impact factor: 56.272

8.  Fistula first is not always the best strategy for the elderly.

Authors:  Ranil N DeSilva; Bhanu K Patibandla; Yael Vin; Akshita Narra; Varun Chawla; Robert S Brown; Alexander S Goldfarb-Rumyantzev
Journal:  J Am Soc Nephrol       Date:  2013-06-27       Impact factor: 10.121

9.  Medicare Costs Associated With Arteriovenous Fistulas Among US Hemodialysis Patients.

Authors:  Mae Thamer; Timmy C Lee; Haimanot Wasse; Marc H Glickman; Joyce Qian; Daniel Gottlieb; Scott Toner; Timothy A Pflederer
Journal:  Am J Kidney Dis       Date:  2018-03-28       Impact factor: 8.860
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.